Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Anne Fuhlbrigge

Concepts (429)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Asthma
98
2025
2295
9.120
 Why?
Adrenal Cortex Hormones
28
2025
565
3.300
 Why?
Anti-Asthmatic Agents
28
2025
395
3.160
 Why?
Forced Expiratory Volume
19
2019
531
1.580
 Why?
Pulmonary Disease, Chronic Obstructive
11
2022
1040
1.380
 Why?
Severity of Illness Index
20
2020
2828
1.000
 Why?
Administration, Inhalation
25
2025
688
0.960
 Why?
Anti-Inflammatory Agents
10
2016
496
0.890
 Why?
Albuterol
5
2015
110
0.850
 Why?
Lung Transplantation
10
2017
313
0.850
 Why?
Bronchodilator Agents
12
2016
252
0.820
 Why?
Budesonide
14
2016
89
0.810
 Why?
Remote Consultation
4
2025
54
0.780
 Why?
Nedocromil
11
2016
32
0.730
 Why?
Humans
129
2025
137585
0.730
 Why?
Nasal Polyps
1
2021
59
0.710
 Why?
Self Report
3
2023
827
0.710
 Why?
Endpoint Determination
2
2020
77
0.690
 Why?
Pharmacogenetics
2
2015
180
0.680
 Why?
Food Hypersensitivity
1
2022
183
0.630
 Why?
Sinusitis
1
2021
221
0.610
 Why?
Virus Diseases
1
2021
212
0.600
 Why?
Lung
7
2019
4060
0.590
 Why?
Physicians
2
2021
910
0.580
 Why?
Glucocorticoids
4
2022
594
0.580
 Why?
Hospitalization
13
2020
2199
0.570
 Why?
Symptom Assessment
1
2019
128
0.570
 Why?
Sleep Apnea, Obstructive
1
2021
293
0.540
 Why?
Oxygen Inhalation Therapy
4
2020
157
0.520
 Why?
Androstadienes
3
2012
107
0.520
 Why?
Child
53
2022
21935
0.510
 Why?
Bone Density
2
2014
489
0.510
 Why?
Disease Progression
14
2020
2757
0.510
 Why?
Managed Care Programs
8
2008
135
0.500
 Why?
Male
82
2025
67762
0.500
 Why?
Emergency Service, Hospital
9
2013
2069
0.500
 Why?
Adult
47
2025
37929
0.490
 Why?
Precision Medicine
1
2020
429
0.480
 Why?
Female
81
2025
73304
0.470
 Why?
Cost Savings
1
2015
84
0.450
 Why?
Patient Reported Outcome Measures
1
2018
402
0.450
 Why?
Adrenergic beta-2 Receptor Agonists
4
2020
37
0.450
 Why?
Practice Patterns, Physicians'
7
2020
1313
0.450
 Why?
Middle Aged
40
2025
33479
0.410
 Why?
Peak Expiratory Flow Rate
2
2011
37
0.410
 Why?
Cost-Benefit Analysis
7
2022
591
0.410
 Why?
Phenotype
6
2025
3196
0.390
 Why?
Comorbidity
4
2021
1622
0.370
 Why?
Academic Medical Centers
3
2024
512
0.360
 Why?
Surveys and Questionnaires
14
2022
5778
0.350
 Why?
Adolescent
37
2019
21513
0.350
 Why?
Administration, Oral
6
2021
816
0.340
 Why?
Quality of Life
12
2023
2892
0.340
 Why?
Medical Records Systems, Computerized
3
2008
96
0.340
 Why?
Mentors
1
2012
202
0.340
 Why?
United States
23
2022
14841
0.330
 Why?
Respiratory Function Tests
10
2015
600
0.330
 Why?
Child, Preschool
31
2016
11074
0.320
 Why?
Treatment Outcome
16
2025
10811
0.310
 Why?
Faculty, Medical
1
2012
283
0.310
 Why?
Interprofessional Relations
3
2021
283
0.310
 Why?
Child Development
1
2014
475
0.310
 Why?
Spirometry
8
2020
281
0.310
 Why?
Oxygen
3
2018
931
0.300
 Why?
Group Practice
1
2008
7
0.290
 Why?
Anti-Allergic Agents
2
2008
46
0.290
 Why?
Aged
22
2022
23961
0.290
 Why?
Computer Simulation
1
2012
978
0.280
 Why?
Dyspnea
3
2022
254
0.270
 Why?
Drug Utilization
4
2005
169
0.260
 Why?
Primary Health Care
5
2025
1738
0.250
 Why?
Primary Graft Dysfunction
2
2017
32
0.250
 Why?
Follow-Up Studies
17
2017
5131
0.250
 Why?
Quality Assurance, Health Care
1
2008
322
0.250
 Why?
Bronchiolitis Obliterans
3
2017
69
0.240
 Why?
Gift Giving
1
2005
11
0.240
 Why?
Diagnostic Techniques, Respiratory System
1
2005
5
0.240
 Why?
Allergists
2
2022
12
0.240
 Why?
Respiratory Sounds
1
2006
125
0.240
 Why?
Genetic Testing
1
2008
460
0.230
 Why?
Randomized Controlled Trials as Topic
7
2020
1477
0.230
 Why?
Delivery of Health Care
2
2021
951
0.230
 Why?
Medication Adherence
2
2023
467
0.220
 Why?
Retrospective Studies
18
2024
15657
0.220
 Why?
Cohort Studies
14
2013
5742
0.220
 Why?
Specialization
2
2025
144
0.210
 Why?
Time Factors
10
2020
6828
0.210
 Why?
Natural Language Processing
1
2025
95
0.210
 Why?
Leadership
2
2022
388
0.210
 Why?
Antibodies, Monoclonal
2
2008
1430
0.210
 Why?
Massachusetts
5
2016
172
0.210
 Why?
Medicine
1
2025
121
0.210
 Why?
Rhinitis, Allergic, Perennial
1
2003
23
0.200
 Why?
Genetic Variation
1
2008
991
0.200
 Why?
Recurrence
5
2013
1060
0.200
 Why?
Health Status
1
2008
792
0.200
 Why?
Steroids
8
2011
167
0.200
 Why?
Genetic Predisposition to Disease
2
2025
2426
0.200
 Why?
Predictive Value of Tests
9
2012
2031
0.190
 Why?
Multicenter Studies as Topic
4
2018
310
0.190
 Why?
Young Adult
11
2019
13209
0.190
 Why?
Beclomethasone
1
2022
27
0.190
 Why?
Prevalence
4
2022
2734
0.190
 Why?
Models, Theoretical
4
2007
578
0.180
 Why?
Desensitization, Immunologic
1
2022
96
0.180
 Why?
Tiotropium Bromide
2
2018
19
0.180
 Why?
Nebulizers and Vaporizers
2
2020
86
0.180
 Why?
Biomarkers
3
2021
4149
0.180
 Why?
Patient Preference
1
2023
191
0.180
 Why?
Social Class
2
2022
282
0.170
 Why?
Churg-Strauss Syndrome
1
2020
26
0.170
 Why?
Pulmonologists
1
2020
14
0.170
 Why?
Bronchoconstriction
3
2011
32
0.170
 Why?
Granulomatosis with Polyangiitis
1
2020
44
0.170
 Why?
Capacity Building
1
2021
63
0.170
 Why?
Muscarinic Antagonists
1
2020
29
0.170
 Why?
Agammaglobulinemia
1
2020
34
0.160
 Why?
Electronic Health Records
2
2025
1069
0.160
 Why?
Physician-Patient Relations
2
2021
548
0.160
 Why?
Risk Factors
12
2018
10388
0.160
 Why?
Practice Guidelines as Topic
5
2020
1587
0.160
 Why?
Air Pollution, Indoor
2
2002
180
0.160
 Why?
Treatment Adherence and Compliance
1
2019
26
0.150
 Why?
Exercise Test
1
2022
625
0.150
 Why?
Receptors, IgE
2
2009
45
0.150
 Why?
Prognosis
8
2017
4030
0.140
 Why?
Allergens
1
2021
409
0.140
 Why?
Vitamin D
2
2012
397
0.140
 Why?
Fossil Fuels
1
1997
10
0.140
 Why?
Emergency Medical Services
2
2007
552
0.140
 Why?
Drug Prescriptions
2
2011
245
0.140
 Why?
Alemtuzumab
1
2017
15
0.140
 Why?
Hypersensitivity
1
2020
257
0.140
 Why?
Photopheresis
1
2017
9
0.140
 Why?
Biological Products
1
2020
216
0.130
 Why?
Respiration
1
2017
199
0.130
 Why?
Respiration Disorders
1
1997
77
0.130
 Why?
Physicians, Primary Care
3
2021
236
0.130
 Why?
Drug Combinations
3
2012
343
0.130
 Why?
Statistics, Nonparametric
1
2017
431
0.130
 Why?
Aged, 80 and over
6
2019
7635
0.130
 Why?
Immunomodulation
1
2017
98
0.130
 Why?
Drug Therapy, Combination
5
2020
1066
0.120
 Why?
Socioeconomic Factors
4
2022
1289
0.120
 Why?
Breath Tests
2
2008
87
0.120
 Why?
Scopolamine Derivatives
1
2015
7
0.120
 Why?
Patient Admission
1
2018
197
0.120
 Why?
Embolism, Fat
1
2015
11
0.120
 Why?
Tobacco Smoke Pollution
2
2010
261
0.120
 Why?
Immunoglobulin G
1
2020
893
0.120
 Why?
Transplants
1
2015
36
0.120
 Why?
Cholinergic Antagonists
1
2015
30
0.120
 Why?
National Heart, Lung, and Blood Institute (U.S.)
1
2015
104
0.120
 Why?
Fluticasone-Salmeterol Drug Combination
2
2012
12
0.120
 Why?
Carcinoma, Bronchogenic
1
2015
20
0.120
 Why?
Referral and Consultation
1
2021
786
0.120
 Why?
Genomics
2
2018
795
0.110
 Why?
Longitudinal Studies
6
2017
2844
0.110
 Why?
Postoperative Complications
2
2017
2654
0.110
 Why?
Overweight
2
2011
558
0.110
 Why?
Respiratory Tract Infections
2
2012
390
0.110
 Why?
Ambulatory Care Information Systems
2
2005
5
0.110
 Why?
Telemedicine
1
2023
862
0.110
 Why?
Prednisolone
1
2014
83
0.110
 Why?
Graft Rejection
2
2013
624
0.110
 Why?
Risk
4
2015
912
0.110
 Why?
Guideline Adherence
3
2020
556
0.110
 Why?
Education, Medical, Continuing
2
2005
127
0.110
 Why?
Airway Obstruction
1
2015
162
0.100
 Why?
Quality Improvement
1
2022
1178
0.100
 Why?
Environmental Exposure
3
2006
579
0.100
 Why?
Forecasting
1
2015
389
0.100
 Why?
Transplantation
1
2013
34
0.100
 Why?
Bronchial Hyperreactivity
3
2010
111
0.100
 Why?
Office Visits
4
2011
93
0.100
 Why?
Insurance Claim Review
1
2013
64
0.100
 Why?
Peer Group
2
2012
242
0.100
 Why?
Medicare
2
2022
773
0.100
 Why?
Double-Blind Method
5
2010
1993
0.100
 Why?
Growth
1
2012
60
0.100
 Why?
Costs and Cost Analysis
1
2013
213
0.100
 Why?
Methacholine Chloride
3
2008
52
0.100
 Why?
Research
1
2015
451
0.100
 Why?
Cytomegalovirus Infections
2
2012
192
0.100
 Why?
Antibodies, Monoclonal, Humanized
2
2008
804
0.100
 Why?
Cost of Illness
3
2003
308
0.090
 Why?
Metered Dose Inhalers
1
2012
16
0.090
 Why?
Feedback
1
2012
173
0.090
 Why?
Drug Dosage Calculations
1
2011
23
0.090
 Why?
Mycoses
1
2012
79
0.090
 Why?
Antifungal Agents
1
2012
136
0.090
 Why?
Logistic Models
5
2017
2074
0.090
 Why?
Body Height
1
2012
199
0.090
 Why?
Effect Modifier, Epidemiologic
1
2011
12
0.090
 Why?
Multivariate Analysis
7
2017
1509
0.090
 Why?
Professional Role
1
2012
167
0.090
 Why?
Morbidity
2
2022
324
0.090
 Why?
Medication Errors
1
2012
95
0.090
 Why?
Mycobacterium
1
2012
108
0.090
 Why?
Epidemiologic Studies
1
2011
72
0.090
 Why?
Obesity
3
2015
2992
0.090
 Why?
Diagnostic Errors
1
2012
170
0.090
 Why?
Patient Readmission
1
2016
697
0.090
 Why?
Secondary Prevention
1
2012
233
0.090
 Why?
Pneumococcal Vaccines
1
2012
142
0.080
 Why?
Program Development
1
2012
364
0.080
 Why?
Drug Resistance
1
2011
169
0.080
 Why?
Lung Diseases
1
2017
767
0.080
 Why?
Probability
1
2011
304
0.080
 Why?
Vitamin D Deficiency
1
2012
186
0.080
 Why?
Chi-Square Distribution
2
2017
530
0.080
 Why?
Bronchial Provocation Tests
2
2008
51
0.080
 Why?
Decision Support Techniques
2
2012
421
0.080
 Why?
Fluticasone
2
2008
90
0.080
 Why?
Ambulatory Care
2
2011
546
0.080
 Why?
Incidence
5
2020
2804
0.080
 Why?
Receptors, Corticotropin-Releasing Hormone
1
2009
29
0.080
 Why?
Vital Capacity
4
2017
311
0.080
 Why?
Immunoglobulin E
2
2008
342
0.080
 Why?
Algorithms
1
2017
1704
0.080
 Why?
Lectins, C-Type
1
2009
67
0.080
 Why?
Proportional Hazards Models
1
2012
1266
0.080
 Why?
Health Services
2
2007
107
0.080
 Why?
Health Knowledge, Attitudes, Practice
2
2012
1329
0.080
 Why?
Medication Therapy Management
1
2010
76
0.080
 Why?
Cross-Sectional Studies
6
2010
5472
0.080
 Why?
Surgical Wound Infection
1
2012
307
0.080
 Why?
Odds Ratio
4
2017
1070
0.080
 Why?
Kaplan-Meier Estimate
3
2016
889
0.080
 Why?
Pandemics
3
2022
1639
0.070
 Why?
Acute Disease
1
2011
1007
0.070
 Why?
Vitamin K Epoxide Reductases
1
2008
12
0.070
 Why?
Cytochrome P-450 CYP2C9
1
2008
20
0.070
 Why?
Eosinophil Cationic Protein
1
2008
10
0.070
 Why?
Smoking
3
2017
1627
0.070
 Why?
Mixed Function Oxygenases
1
2008
40
0.070
 Why?
Program Evaluation
1
2012
898
0.070
 Why?
Aryl Hydrocarbon Hydroxylases
1
2008
48
0.070
 Why?
Genetic Techniques
1
2008
64
0.070
 Why?
Trastuzumab
1
2008
96
0.070
 Why?
Quality-Adjusted Life Years
2
2006
113
0.070
 Why?
Insurance, Pharmaceutical Services
1
2008
22
0.070
 Why?
Markov Chains
2
2006
126
0.070
 Why?
Cost Sharing
1
2008
15
0.070
 Why?
State Health Plans
1
2008
30
0.070
 Why?
Adrenergic beta-Agonists
1
2008
134
0.070
 Why?
Smoking Cessation
1
2012
442
0.070
 Why?
Reimbursement Mechanisms
1
2008
85
0.070
 Why?
Interviews as Topic
1
2011
786
0.070
 Why?
Antibodies, Anti-Idiotypic
1
2007
59
0.070
 Why?
Chronic Disease
3
2017
1793
0.070
 Why?
Exercise Tolerance
2
2022
279
0.070
 Why?
Omalizumab
1
2007
51
0.070
 Why?
Warfarin
1
2008
154
0.070
 Why?
Mycobacterium Infections, Nontuberculous
1
2012
363
0.070
 Why?
Factor Analysis, Statistical
1
2008
283
0.070
 Why?
Health Surveys
2
2006
514
0.070
 Why?
Health Services Accessibility
2
2021
986
0.070
 Why?
Influenza Vaccines
1
2012
539
0.070
 Why?
Databases, Factual
1
2012
1357
0.070
 Why?
Antiviral Agents
1
2012
744
0.070
 Why?
Tomography, X-Ray Computed
1
2017
2691
0.070
 Why?
Animals, Domestic
1
2006
17
0.060
 Why?
Lung Diseases, Interstitial
1
2013
638
0.060
 Why?
Animals
2
2025
36940
0.060
 Why?
Receptor, ErbB-2
1
2008
341
0.060
 Why?
Physicians, Family
2
2004
201
0.060
 Why?
Eosinophils
1
2008
332
0.060
 Why?
Biomedical Research
1
2012
692
0.060
 Why?
Health Benefit Plans, Employee
1
2005
25
0.060
 Why?
Database Management Systems
1
2005
51
0.060
 Why?
Models, Biological
1
2012
1783
0.060
 Why?
Hip Fractures
1
2006
86
0.060
 Why?
Patients
1
2006
175
0.060
 Why?
Health Policy
1
2008
388
0.060
 Why?
Insurance Coverage
1
2006
230
0.060
 Why?
Infant
3
2008
9465
0.060
 Why?
Utilization Review
1
2004
36
0.050
 Why?
Patient Education as Topic
3
2005
766
0.050
 Why?
Body Mass Index
3
2015
2389
0.050
 Why?
Clinical Competence
1
2012
1118
0.050
 Why?
Prenatal Exposure Delayed Effects
1
2010
605
0.050
 Why?
Gene Expression Profiling
1
2011
1774
0.050
 Why?
Medicaid
1
2008
435
0.050
 Why?
Anticoagulants
1
2008
664
0.050
 Why?
Mass Screening
1
2012
1287
0.050
 Why?
Vaccination
1
2012
1381
0.050
 Why?
Sex Factors
3
2016
2071
0.050
 Why?
Attitude to Health
1
2006
439
0.050
 Why?
Nitric Oxide
1
2008
915
0.050
 Why?
Anti-Bacterial Agents
2
2004
1809
0.050
 Why?
Case Management
1
2003
66
0.050
 Why?
Clinical Trials as Topic
2
2005
1050
0.050
 Why?
Parents
3
2006
1347
0.050
 Why?
Puerto Rico
1
2022
53
0.050
 Why?
Choice Behavior
1
2004
170
0.050
 Why?
Circadian Rhythm
1
2006
468
0.050
 Why?
Symptom Flare Up
1
2022
39
0.050
 Why?
Sputum
1
2004
311
0.050
 Why?
Academies and Institutes
1
2022
53
0.050
 Why?
Lung Neoplasms
1
2015
2526
0.040
 Why?
Health Services Research
1
2004
404
0.040
 Why?
Minority Groups
1
2003
266
0.040
 Why?
Survival Rate
2
2016
1972
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2020
76
0.040
 Why?
Electronics
1
2021
76
0.040
 Why?
Clinical Trials, Phase III as Topic
1
2020
106
0.040
 Why?
Sample Size
1
2020
125
0.040
 Why?
Efficiency
1
2021
99
0.040
 Why?
Health Care Reform
1
2021
107
0.040
 Why?
Pragmatic Clinical Trials as Topic
1
2020
65
0.040
 Why?
Schools, Medical
1
2021
147
0.040
 Why?
Risk Assessment
3
2020
3457
0.040
 Why?
Patient Selection
2
2020
696
0.040
 Why?
Patient Compliance
2
2016
581
0.040
 Why?
Language
1
2022
292
0.040
 Why?
Stress, Psychological
1
2007
1100
0.040
 Why?
Time
1
2019
83
0.040
 Why?
Cluster Analysis
2
2014
499
0.040
 Why?
Health Education
1
2002
341
0.040
 Why?
Quality of Health Care
1
2003
642
0.040
 Why?
Poland
1
2017
35
0.040
 Why?
Republic of Korea
1
2017
37
0.040
 Why?
Bronchitis, Chronic
1
2017
25
0.040
 Why?
Cooperative Behavior
1
2021
451
0.030
 Why?
Patient-Centered Care
1
2003
530
0.030
 Why?
Sensitivity and Specificity
3
2013
1946
0.030
 Why?
Nitrogen Dioxide
1
1997
47
0.030
 Why?
Geography
1
2018
200
0.030
 Why?
Aftercare
1
2019
208
0.030
 Why?
Long-Term Care
1
2018
107
0.030
 Why?
Self Concept
1
2019
253
0.030
 Why?
Monitoring, Physiologic
2
2012
275
0.030
 Why?
Netherlands
1
2016
88
0.030
 Why?
Pediatrics
1
2005
1101
0.030
 Why?
Antineoplastic Agents
1
2008
2129
0.030
 Why?
Tuberculosis, Pulmonary
1
2017
141
0.030
 Why?
Perception
1
2019
359
0.030
 Why?
Formoterol Fumarate
1
2015
7
0.030
 Why?
Forced Expiratory Flow Rates
1
2015
14
0.030
 Why?
Ethanolamines
1
2015
17
0.030
 Why?
Salmeterol Xinafoate
1
2015
41
0.030
 Why?
Feasibility Studies
1
2020
956
0.030
 Why?
Receptors, Adrenergic, beta-2
1
2015
45
0.030
 Why?
Treatment Failure
1
2016
356
0.030
 Why?
Postoperative Period
1
2016
342
0.030
 Why?
Dose-Response Relationship, Drug
2
2011
2057
0.030
 Why?
Self Efficacy
1
2019
396
0.030
 Why?
Education
1
2015
108
0.030
 Why?
Polymorphism, Single Nucleotide
2
2016
2189
0.030
 Why?
Age Factors
3
2008
3295
0.030
 Why?
Fatal Outcome
1
2015
303
0.030
 Why?
Immunosuppressive Agents
2
2015
890
0.030
 Why?
Pilot Projects
1
2020
1710
0.030
 Why?
Patient Acceptance of Health Care
1
2021
806
0.030
 Why?
Biopsy
2
2013
1129
0.030
 Why?
Combined Modality Therapy
1
2017
1236
0.030
 Why?
Gene Expression
1
2018
1502
0.030
 Why?
Telephone
2
2005
173
0.020
 Why?
Echinocandins
1
2012
7
0.020
 Why?
Lipopeptides
1
2012
13
0.020
 Why?
Amphotericin B
1
2012
31
0.020
 Why?
Aspergillosis
1
2012
21
0.020
 Why?
Intention to Treat Analysis
1
2012
73
0.020
 Why?
Candidiasis
1
2012
56
0.020
 Why?
Tissue Donors
1
2015
425
0.020
 Why?
Transplantation, Homologous
1
2013
416
0.020
 Why?
Extracorporeal Membrane Oxygenation
1
2015
301
0.020
 Why?
Hypoxia
1
2019
1112
0.020
 Why?
Mycobacterium avium Complex
1
2012
88
0.020
 Why?
Age Distribution
2
2003
392
0.020
 Why?
Cromolyn Sodium
2
2001
11
0.020
 Why?
Triazoles
1
2012
147
0.020
 Why?
Leukotriene Antagonists
1
2011
43
0.020
 Why?
Self Care
2
2005
380
0.020
 Why?
Functional Residual Capacity
1
2010
8
0.020
 Why?
Reference Values
1
2012
816
0.020
 Why?
Colorado
1
2021
4565
0.020
 Why?
Costa Rica
1
2010
19
0.020
 Why?
Principal Component Analysis
1
2011
195
0.020
 Why?
Nontuberculous Mycobacteria
1
2012
205
0.020
 Why?
Health
1
2010
84
0.020
 Why?
Inhalation
1
2010
29
0.020
 Why?
Genome-Wide Association Study
1
2016
1431
0.020
 Why?
Environment
1
2011
358
0.020
 Why?
Observation
1
2008
50
0.020
 Why?
Sex Ratio
1
2008
14
0.020
 Why?
Least-Squares Analysis
1
2008
79
0.020
 Why?
Models, Econometric
1
2008
34
0.020
 Why?
Prospective Studies
2
2012
7604
0.020
 Why?
Health Services Administration
1
2007
8
0.020
 Why?
Treatment Refusal
1
2008
89
0.020
 Why?
Social Isolation
1
2007
62
0.020
 Why?
Intelligence
1
2007
123
0.020
 Why?
Puberty
1
2008
146
0.020
 Why?
Body Weight
1
2011
985
0.020
 Why?
Child Behavior Disorders
1
2007
144
0.020
 Why?
Exercise
1
2016
2057
0.010
 Why?
Insurance, Health
1
2007
283
0.010
 Why?
CD4-Positive T-Lymphocytes
1
2011
1091
0.010
 Why?
Genotype
1
2009
1916
0.010
 Why?
Bronchoconstrictor Agents
1
2003
16
0.010
 Why?
Health Status Indicators
1
2004
171
0.010
 Why?
Organizational Innovation
1
2004
140
0.010
 Why?
Case-Control Studies
1
2010
3556
0.010
 Why?
Systems Integration
1
2003
37
0.010
 Why?
Computer Systems
1
2003
45
0.010
 Why?
Motor Activity
1
2007
718
0.010
 Why?
Child Welfare
1
2004
216
0.010
 Why?
Self Disclosure
1
2002
63
0.010
 Why?
Histamine H1 Antagonists
1
2002
30
0.010
 Why?
Drug Administration Schedule
1
2004
786
0.010
 Why?
Administration, Intranasal
1
2002
90
0.010
 Why?
Confidence Intervals
1
2002
329
0.010
 Why?
Regression Analysis
1
2003
1024
0.010
 Why?
Nurse's Role
1
2003
161
0.010
 Why?
Point-of-Care Systems
1
2003
167
0.010
 Why?
Health Care Surveys
1
2002
565
0.010
 Why?
Sex Distribution
1
2001
375
0.010
 Why?
Patient Satisfaction
1
2004
660
0.010
 Why?
Decision Support Systems, Clinical
1
2003
226
0.010
 Why?
Linear Models
1
2002
849
0.010
 Why?
Caregivers
1
2007
877
0.010
 Why?
Disease Management
1
2003
628
0.010
 Why?
Bronchoscopy
1
2000
223
0.010
 Why?
Internet
1
2003
655
0.010
 Why?
Pregnancy
1
2010
6763
0.010
 Why?
Survival Analysis
1
2000
1325
0.010
 Why?
Infant, Newborn
1
2004
6079
0.010
 Why?
Fuhlbrigge's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (429) concept(s)
_
Co-Authors Expand Description
See all (19) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)